BIOR News and Press, Biora Therapeutics Inc. From 04/04/24

2024-04-04 08:55:21 ET More on Biora Therapeutics Biora Therapeutics, Inc. (BIOR) Q4 2023 Earnings Call Transcript Biora Therapeutics announces $6M registered direct offering and concurrent private placement Biora Therapeutics announces new capital investment ...

All pharmacokinetic endpoints were achieved, with a PK profile consistent with drug delivery and absorption in the colon All NaviCap™ devices performed as intended and were well tolerated, with no safety signals observed Multiple-ascending dose (MAD) portion of the trial ...

SAN DIEGO, April 03, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced the closing of its previously announced registered direct offering of an aggregate of 5,454,548 shares of the Company’s ...

2024-04-01 12:57:59 ET More on Mid-day movers & stocks. Meta Materials total Q4 revenue up 55% y/y Meta Materials announces $1M civil penalty to settle SEC investigation Seeking Alpha’s Quant Rating on Connect Biopharma Historical earnings data for...

A look at the top 10 most actives in the United States Sunshine Biopharma Inc. (SBFM) rose 93.4% to $0.117 on volume of 124,152,860 shares Jaguar Health Inc. (JAGX) fell 9.0% to $0.0818 on volume of 39,020,683 shares CXApp Inc. (CXAI) rose 82.9% to $4.48 on volume of 34,784,405 shares N...

2024-04-01 08:34:27 ET More on Biora Therapeutics Biora Therapeutics announces new capital investment Seeking Alpha’s Quant Rating on Biora Therapeutics Historical earnings data for Biora Therapeutics Financial information for Biora Therapeutics ...

2024-04-01 08:31:15 ET More on Pre-market losers & stocks. MicroStrategy Is A $1 Box Of Bitcoin Trading For $1.91 Biora Therapeutics, Inc. (BIOR) Q4 2023 Earnings Call Transcript MicroStrategy: A Bad Deal For Investors MicroStrategy among most squeezable ...

SAN DIEGO, April 01, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it has entered into definitive agreements for the purchase and sale of 5,454,548 shares of the Company’s common sto...

2024-03-26 19:54:08 ET Biora Therapeutics, Inc. (BIOR) Q4 2023 Results Conference Call March 26, 2024 04:30 PM ET Company Participants Chuck Pedala - LifeSci Advisors Adi Mohanty - CEO Ariella Kelman - Chief Medical Officer Eric d'Esparbes - CFO Confere...

2024-03-26 16:12:23 ET More on Biora Therapeutics Biora Therapeutics announces new capital investment Seeking Alpha’s Quant Rating on Biora Therapeutics Historical earnings data for Biora Therapeutics Financial information for Biora Therapeutics ...